Migdal Insurance & Financial Holdings Ltd. trimmed its position in shares of Medtronic PLC (NYSE:MDT) by 23.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,294 shares of the medical technology company’s stock after selling 1,618 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in Medtronic PLC were worth $470,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. boosted its stake in shares of Medtronic PLC by 2,513.4% during the first quarter. BlackRock Inc. now owns 87,035,376 shares of the medical technology company’s stock valued at $7,011,571,000 after purchasing an additional 83,705,052 shares during the period. Lazard Asset Management LLC boosted its stake in shares of Medtronic PLC by 1,061.4% during the first quarter. Lazard Asset Management LLC now owns 13,678,772 shares of the medical technology company’s stock valued at $1,101,960,000 after purchasing an additional 12,500,992 shares during the period. Vanguard Group Inc. boosted its stake in shares of Medtronic PLC by 4.5% during the first quarter. Vanguard Group Inc. now owns 102,321,656 shares of the medical technology company’s stock valued at $8,243,034,000 after purchasing an additional 4,412,536 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Medtronic PLC by 135.5% during the second quarter. Alliancebernstein L.P. now owns 6,070,160 shares of the medical technology company’s stock valued at $538,727,000 after purchasing an additional 3,493,058 shares during the period. Finally, Sanders Capital LLC boosted its stake in shares of Medtronic PLC by 43.7% during the second quarter. Sanders Capital LLC now owns 6,670,948 shares of the medical technology company’s stock valued at $651,800,000 after purchasing an additional 2,027,147 shares during the period. 81.14% of the stock is owned by institutional investors.

A number of analysts have recently issued reports on the stock. SunTrust Banks, Inc. set a $92.00 target price on shares of Medtronic PLC and gave the company a “buy” rating in a research note on Sunday. Needham & Company LLC reissued a “buy” rating and set a $94.00 target price on shares of Medtronic PLC in a research note on Thursday, November 9th. Cowen and Company restated a “buy” rating and issued a $95.00 price objective on shares of Medtronic PLC in a report on Friday, November 3rd. BMO Capital Markets restated an “outperform” rating and issued a $89.00 price objective (down from $92.00) on shares of Medtronic PLC in a report on Tuesday, October 10th. Finally, Leerink Swann restated a “market perform” rating and issued a $85.00 price objective (down from $88.00) on shares of Medtronic PLC in a report on Monday, October 9th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $87.69.

ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/22/medtronic-plc-mdt-holdings-reduced-by-migdal-insurance-financial-holdings-ltd.html.

In other Medtronic PLC news, EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $78.03, for a total value of $1,248,480.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $81.63, for a total value of $11,461,423.41. Following the completion of the sale, the chief executive officer now owns 668,503 shares in the company, valued at approximately $54,569,899.89. The disclosure for this sale can be found here. In the last 90 days, insiders sold 172,407 shares of company stock worth $13,974,223. Insiders own 0.31% of the company’s stock.

Shares of Medtronic PLC (NYSE:MDT) opened at $82.66 on Wednesday. The company has a market capitalization of $106,877.23, a P/E ratio of 16.82, a P/E/G ratio of 2.12 and a beta of 1.00. Medtronic PLC has a 52-week low of $69.35 and a 52-week high of $89.72. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.64 and a quick ratio of 1.40.

Medtronic PLC (NYSE:MDT) last issued its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. Medtronic PLC had a return on equity of 12.92% and a net margin of 13.75%. The firm had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. During the same quarter in the prior year, the firm earned $1.12 earnings per share. Medtronic PLC’s revenue for the quarter was down 4.0% on a year-over-year basis. equities analysts expect that Medtronic PLC will post 4.69 EPS for the current year.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Stock Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related stocks with our FREE daily email newsletter.